Authors:
RUUTU T
LJUNGMAN P
BRINCH L
LENHOFF S
LONNQVIST B
RINGDEN O
RUUTU P
VOLIN L
ALBRECHTSEN D
SALLERFORS B
EBELING F
MYLLYLA G
Citation: T. Ruutu et al., NO PREVENTION OF CYTOMEGALOVIRUS-INFECTION BY ANTICYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN IN SERONEGATIVE BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 19(3), 1997, pp. 233-236
Authors:
PFEFFER PF
LEIVESTAD T
ALBRECHTSEN D
FAUCHALD P
BREKKE IB
Citation: Pf. Pfeffer et al., ANAMNESTIC CANCER - HOW LONG SHOULD THE CANCER-FREE INTERVAL BE BEFORE RENAL-TRANSPLANTATION, Transplantation proceedings, 29(7), 1997, pp. 3163-3163
Authors:
KOVARIK JM
RAWLINGS E
SWENY P
FERNANDO O
MOORE R
GRIFFIN PJ
FAUCHALD P
ALBRECHTSEN D
SODAL G
NORDAL K
AMLOT PL
Citation: Jm. Kovarik et al., PROLONGED IMMUNOSUPPRESSIVE EFFECT AND MINIMAL IMMUNOGENICITY FROM CHIMERIC (CD25) MONOCLONAL-ANTIBODY SDZ-CHI-621 IN RENAL-TRANSPLANTATION, Transplantation proceedings, 28(2), 1996, pp. 913-914
Authors:
GRINYO J
GROTH C
PICHLMAYR R
SADEK SA
VANRENTERGHEM Y
BEHREND M
LUCK R
MORESO F
PEETERS J
RODICIO J
MORALES J
ALBRECHTSEN D
FAUCHALD P
SADEK S
LODGE J
SOULILLOU JP
CANTAROVICH D
VANSON W
TEGZESS A
WAGNER K
ERHARD J
BRATTSTROM C
MJORNSTEDT L
WIESEL M
CARL S
NEUMAYER HH
HAUSER I
LANG P
BOURGEON B
TUFVESON G
GANNEDAHL G
EKBERG H
PERSSON N
TARANTINO A
CAMPISE M
THIEL G
ZEILER M
HENE R
LIGTENBERG G
MORGAN A
RIGG K
HOOFTMAN L
HUTCHINSON K
Citation: J. Grinyo et al., PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION, Lancet, 345(8961), 1995, pp. 1321-1325
Authors:
LINDHOLM A
ALBRECHTSEN D
FRODIN L
TUFVESON G
PERSSON NH
LUNDGREN G
Citation: A. Lindholm et al., ISCHEMIC-HEART-DISEASE - MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL-TRANSPLANTATION IN SCANDINAVIA, Transplantation, 60(5), 1995, pp. 451-457
Authors:
REISAETER AV
LEIVESTAD T
ALBRECHTSEN D
HOLDAAS H
HARTMANN A
SODAL G
FLATMARK A
FAUCHALD P
Citation: Av. Reisaeter et al., PRETRANSPLANT PLASMA-EXCHANGE OR IMMUNOADSORPTION FACILITATES RENAL-TRANSPLANTATION IN IMMUNIZED PATIENTS, Transplantation, 60(3), 1995, pp. 242-248
Authors:
LINDHOLM A
ALBRECHTSEN D
FLATMARK A
TUFVESON G
PERSSON NH
FRODIN L
GROTH CG
Citation: A. Lindholm et al., A RANDOMIZED MULTICENTER TRIAL OF CYCLOSPORINE AND PREDNISOLONE VERSUS CYCLOSPORINE, AZATHIOPRINE, AND PREDNISOLONE FOLLOWING PRIMARY LIVING DONOR RENAL-TRANSPLANTATION, Transplant international, 7(3), 1994, pp. 207-215
Authors:
BUCIN D
EKBERG H
LINDHOLM A
PERSSON H
TUFVESON G
ALBRECHTSEN D
Citation: D. Bucin et al., HLA-A INCOMPATIBILITY ASSOCIATED WITH ENHANCED LONG-TERM RENAL GRAFT-SURVIVAL IN HLA-B, DR MISMATCHED TRANSPLANTS, Immunology and cell biology, 72(6), 1994, pp. 455-460
Authors:
FAUCHALD P
LEIVESTAD T
ROLLAG H
ALBRECHTSEN D
SODAL G
Citation: P. Fauchald et al., INFLUENCE OF CYTOMEGALOVIRUS ANTIBODY STATUS ON GRAFT-SURVIVAL IN RENAL-TRANSPLANTATION, Transplantation proceedings, 26(3), 1994, pp. 1725-1725
Citation: L. Brinch et al., INCREASING AGE AND SURVIVAL AFTER BONE-MARROW TRANSPLANT, JAMA, the journal of the American Medical Association, 270(21), 1993, pp. 2560-2560
Authors:
LINDHOLM A
OHLMAN S
ALBRECHTSEN D
TUFVESON G
PERSSON H
PERSSON NH
Citation: A. Lindholm et al., THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL-TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENS, Transplantation, 56(2), 1993, pp. 307-315